Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Mol Biol Rep ; 51(1): 718, 2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38824224

RÉSUMÉ

BACKGROUND: Breast cancer is one of the most common diseases in females, arising from overexpression of a variety of oncogenes like HER2/neu. The amplification rate of this gene is variable in different breast cancer patients. In this study, the amplification of the HER2/neu oncogene was distinguished in breast cancer patients and its correlation with prognostic factors. Also, the simultaneous effect of prognostic factors on the occurrence of a specific prognostic factor was investigated. MATERIALS AND METHODS: The multiplex PCR technique was used to assay the amplification of the HER2/neu oncogene in breast cancer patients. After extracting DNA from 100 tumor tissue and 8 normal breast tissue samples, the amplification of the HER2/neu gene was distinguished by the co-amplification of a single-copy reference gene, γ-IFN, and the target gene HER2/neu in the PCR reaction and using the Gel analyzer software. SPSS 23 and STATA 9.1 software were used for statistical analysis. RESULTS: The HER2/neu gene was amplification in 30% of the tumor samples. The statistical analysis showed a statistically significant relationship between HER2/neu gene amplification and progesterone receptors. Amplification of the HER2/neu gene significantly increases the chance of lymph node involvement. Also, the amplification of this gene in tumors with histological grade II tissue is more than grade I. CONCLUSION: The amplification of the HER2/neu gene can be used as an independent prognostic factor in predicting lymph node involvement and histological grade in breast cancer patients.


Sujet(s)
Tumeurs du sein , Amplification de gène , Récepteur ErbB-2 , Humains , Tumeurs du sein/génétique , Tumeurs du sein/anatomopathologie , Femelle , Pronostic , Récepteur ErbB-2/génétique , Récepteur ErbB-2/métabolisme , Iran , Adulte d'âge moyen , Adulte , Sujet âgé
2.
Mutat Res Rev Mutat Res ; 790: 108442, 2022.
Article de Anglais | MEDLINE | ID: mdl-36089265

RÉSUMÉ

Diabetes, one of the most common multifactorial metabolic disorders, is a jeopardizing cause of human health worldwide. MicroRNAs (miRNAs) are a group of small non-coding RNAs that have been contributed to the regulation of gene expression through post-transcriptional mechanisms. The potential role of miRNAs has been studied in the most of biological processes and mechanisms underlying the progression of variety diseases including diabetes. In this review, we focus on the role of miRNAs in regulating pivotal molecular and cellular mechanisms associated with immune system that progress diabetic disorders.


Sujet(s)
Diabète , Système immunitaire , microARN , Humains , Diabète/génétique , Diabète/immunologie , microARN/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE